Isovaleramide structure
|
Common Name | Isovaleramide | ||
|---|---|---|---|---|
| CAS Number | 541-46-8 | Molecular Weight | 101.14700 | |
| Density | 0.901g/cm3 | Boiling Point | 232°C | |
| Molecular Formula | C5H11NO | Melting Point | 135 °C | |
| MSDS | N/A | Flash Point | 232°C | |
Use of IsovaleramideIsovaleramide is an active principle on central nervous system from Valeriana pavonii, as an anticonvulsant.Target:in vitro: Isovaleramide (300 μM) exhibits a 42% of inhibition of the binding of 3H-FNZ to its sites.in vivo: Isovaleramide at 100 mg/Kg, p.o, evidences a 90% index protection against the maximal electroshock seizure in mice (MES). |
| Name | 3-methylbutanamide |
|---|---|
| Synonym | More Synonyms |
| Description | Isovaleramide is an active principle on central nervous system from Valeriana pavonii, as an anticonvulsant.Target:in vitro: Isovaleramide (300 μM) exhibits a 42% of inhibition of the binding of 3H-FNZ to its sites.in vivo: Isovaleramide at 100 mg/Kg, p.o, evidences a 90% index protection against the maximal electroshock seizure in mice (MES). |
|---|---|
| Related Catalog |
| Density | 0.901g/cm3 |
|---|---|
| Boiling Point | 232°C |
| Melting Point | 135 °C |
| Molecular Formula | C5H11NO |
| Molecular Weight | 101.14700 |
| Flash Point | 232°C |
| Exact Mass | 101.08400 |
| PSA | 43.09000 |
| LogP | 1.21810 |
| Index of Refraction | 1.425 |
| InChIKey | SANOUVWGPVYVAV-UHFFFAOYSA-N |
| SMILES | CC(C)CC(N)=O |
| Storage condition | -20℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xi |
|---|---|
| Safety Phrases | S22-S24/25 |
| RTECS | EJ3650000 |
| HS Code | 2924199090 |
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Name: Michaelis-Menten's constant was determined in vivo against rat liver alcohol dehydrog...
Source: ChEMBL
Target: N/A
External Id: CHEMBL644079
|
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VER...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4513082
|
|
Name: Primary high throughput screening by co-culture imaging for identification hits as a ...
Source: 23209
Target: N/A
External Id: UIHTS20180925
|
|
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Cac...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4303805
|
|
Name: Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in H...
Source: Southern Research Institute
Target: CFTR
External Id: CF Folding
|
|
Name: SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response f...
Source: ChEMBL
Target: Replicase polyprotein 1ab
External Id: CHEMBL4495582
|
|
Name: Stabilization of p53 in human papillomavirus-positive cells
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Cellular tumor antigen p53
External Id: HMS1485
|
|
Name: Identifying Sarm1 Tir Hydrolase inhibitors through NAD-Glo assay
Source: 24386
Target: N/A
External Id: Sarm1 Tir NADase inhibitors screen
|
|
Name: In vivo inhibition of ethanol metabolism following 1 mMol/Kg p.o.
Source: ChEMBL
Target: N/A
External Id: CHEMBL787792
|
| Isopentanamide |
| 3-Methylbutyramide |
| Butanamide,3-methyl |
| dimethyl propionic acid amide |
| 3-methylbutaneamide |
| MFCD00014807 |
| Isovaleric acid amide |
| dimethyl propionamide |
| Isovaleramide |
| 3-Methylbutanamide |
| 3-methylbutylamide |
| EINECS 208-781-1 |
| NPS 1776 |
| Isovaleric amide |